13F Holdings
中文EN

CGC Canopy Growth Corp

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1737927 · Reporting currency CAD · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.7%
TTM net income YoY21.3%
TTM EPS YoY66.5%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—

Margins

Gross margin24.4%
Operating margin-54.2%
Net margin-87.8%
FCF margin-25.8%
EBITDA margin-47.5%

Returns

ROE-39.5%
ROA-25.4%
ROIC (approx.)-20.3%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets38.5%
Debt / equity0.38x
Current ratio2.82x
Interest coverage-3.69x

Cash quality & payout

Operating cash flow / net income0.27x
Accruals ratio-18.6%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD 2027Q22026-09-302026Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue81.37M81.17M71.25M74.54M66.68M72.13M65.03M74.76M
Cost of revenue58.02M58.93M62.98M53.08M44.78M54.10M54.49M50.66M
Gross profit23.36M22.24M8.26M21.47M21.91M18.04M10.54M24.10M
SG&A expense39.69M40.22M41.14M44.44M36.30M38.11M38.45M41.48M
Operating income-22.96M-22.11M-95.79M-26.35M-16.89M-22.62M-18.27M-23.82M
Interest expense13.02M12.68M12.31M7.34M8.80M9.74M15.38M16.77M
Pretax income-41.49M-14.71M-155.57M-57.98M-4.76M-44.57M-196.34M-97.77M
Income tax-800,000-129,000-850,000368,000214,000291,000329,000316,000
Net income-40.69M-14.58M-157.12M-58.34M-4.98M-44.86M-195.96M-98.08M
EBITDA-17.20M-16.76M-91.05M-21.60M-12.12M-17.87M-12.32M-18.88M
EPS (basic)-0.10-0.03—-0.17-0.02-0.24—-0.89
EPS (diluted)-0.10-0.03—-0.17-0.02-0.24—-0.89
Weighted avg. shares (diluted)423.11M422.26M—345.53M274.03M188.32M—110.31M
Balance sheet
Cash & equivalents247.34M336.62M364.68M371.32M298.06M126.20M113.81M161.91M
Short-term investments72.45M—00017.43M17.66M16.43M
Receivables31.74M32.55M31.24M29.00M24.56M47.97M47.51M44.39M
Inventory105.09M107.46M110.51M105.56M102.37M93.82M96.37M90.75M
Current assets480.78M506.36M529.47M524.67M445.82M303.36M294.57M341.08M
PP&E, net304.30M311.20M316.49M285.04M288.82M291.27M293.52M299.60M
Goodwill55.69M55.69M55.69M47.52M48.24M47.38M46.04M44.09M
Intangibles85.48M88.48M92.41M76.17M81.15M84.33M87.20M89.79M
Total assets1.06B1.10B1.12B1.11B1.07B904.67M917.70M1.16B
Current liabilities170.61M166.75M158.44M109.33M96.42M110.65M103.05M130.50M
Short-term debt43.13M28.82M16.24M01.85M6.31M4.26M3.17M
Long-term debt202.73M211.38M217.12M224.99M226.33M289.00M299.81M438.40M
Total debt245.86M240.20M233.36M224.99M228.18M295.30M304.07M441.57M
Total liabilities407.48M415.29M421.14M359.06M349.14M427.68M439.13M606.22M
Shareholders' equity650.32M688.63M697.59M747.13M720.69M477.00M478.57M558.00M
Net debt-1.48M-96.42M-131.32M-146.33M-69.88M169.10M190.26M279.66M
Shares outstanding423.35M423.02M422.07M368.28M332.38M205.15M183.87M129.15M
Cash flow statement
Operating cash flow-12.57M-25.01M-18.25M-17.24M-17.98M-10.34M-33.15M-26.97M
Capital expenditure2.98M737,0001.00M1.80M1.23M1.31M3.09M1.22M
Free cash flow-15.55M-25.75M-19.25M-19.04M-19.20M-11.64M-36.24M-28.18M
Investing cash flow-75.17M-737,000-42.65M5.27M16.73M-705,000-1.00M-14.79M
Financing cash flow-498,000-7.47M46.61M91.34M169.00M25.46M-15.96M-30.10M
Depreciation & amortization5.76M5.35M4.75M4.75M4.78M4.75M5.95M4.94M
Stock-based compensation4.03M1.36M1.47M888,0002.01M-99,000-18.74M5.16M

Free plan shows the latest 8 periods; Pro shows all 34 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.